HIV Disclosure and Medication Adherence, a Pilot Study

The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Infection Behavior Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Health Behavior Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Medication Adherence Patient Acceptance of Health Care Patient Compliance RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Treatment Adherence and Compliance Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Policlinique Médicale Universitaire

Lausanne, Canton of Vaud, 1011, Switzerland

About this study

Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation.

Adherence is measured by electronic monitoring and pill count.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

HIV Infection
Enrolled in the adherence-enhancing program

Exclusion criteria

Inclusion visit
Not french or english speaker

Treatment and study plan

Primary outcomes

Patient Adherence

Time frame: 30 days before survey

Electronic monitoring of adherence during 30 days before survey

Secondary outcomes

Patient Adherence

Time frame: 90 days before survey

Electronic monitoring of adherence during 90 days before survey

Sponsors and collaborators

Lead sponsor

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Other

Collaborators

Centre Hospitalier Universitaire Vaudois
Swiss HIV Cohort Study

Registry information

Acronym: RSAD-VIH-11

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Jun 18, 2012
Registry last updated: Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed